Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

A new hydrate form of diflunisal precipitated from a microemulsion system.

Sung HL, Fan YL, Yeh K, Chen YF, Chen LJ.

Colloids Surf B Biointerfaces. 2013 Sep 1;109:68-73. doi: 10.1016/j.colsurfb.2013.03.043. Epub 2013 Apr 6.

PMID:
23624616
2.

Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.

Martínez-Ohárriz MC, Martín C, Goñi MM, Rodríguez-Espinosa C, Tros de Ilarduya-Apaolaza MC, Sánchez M.

J Pharm Sci. 1994 Feb;83(2):174-7.

PMID:
8169784
3.

Pharmaceutical cocrystals of diflunisal and diclofenac with theophylline.

Surov AO, Voronin AP, Manin AN, Manin NG, Kuzmina LG, Churakov AV, Perlovich GL.

Mol Pharm. 2014 Oct 6;11(10):3707-15. doi: 10.1021/mp5004652. Epub 2014 Sep 11.

PMID:
25184906
4.

Enhancement of dissolution rate of mitotane and warfarin prepared by using microemulsion systems.

Lin YH, Chen YS, Wu TC, Chen LJ.

Colloids Surf B Biointerfaces. 2011 Jul 1;85(2):366-72. doi: 10.1016/j.colsurfb.2011.03.015. Epub 2011 Mar 23.

PMID:
21478000
5.

An insight on human skin penetration of diflunisal: lipogel versus hydrogel microemulsion.

Sallam MA, Motawaa AM, Mortada SM.

Drug Dev Ind Pharm. 2015 Jan;41(1):141-7. doi: 10.3109/03639045.2013.850711. Epub 2013 Oct 31.

PMID:
24171693
6.

A thermodynamic based approach on the investigation of a diflunisal pharmaceutical co-crystal with improved intrinsic dissolution rate.

Evora AO, Castro RA, Maria TM, Silva MR, Ter Horst JH, Canotilho J, Eusébio ME.

Int J Pharm. 2014 May 15;466(1-2):68-75. doi: 10.1016/j.ijpharm.2014.02.048. Epub 2014 Mar 4.

PMID:
24607201
7.

Nitrofurantoin-p-aminobenzoic acid cocrystal: hydration stability and dissolution rate studies.

Cherukuvada S, Babu NJ, Nangia A.

J Pharm Sci. 2011 Aug;100(8):3233-44. doi: 10.1002/jps.22546. Epub 2011 Mar 18.

PMID:
21425165
8.

Evaluation of the drug-polymer interaction in calcium alginate beads containing diflunisal.

Mandal B, Alexander KS, Riga AT.

Pharmazie. 2010 Feb;65(2):106-9.

PMID:
20225653
9.

Screening and Characterization of Hydrate Forms of T-3256336, a Novel Inhibitor of Apoptosis (IAP) Protein Antagonist.

Takeuchi S, Kojima T, Hashimoto K, Saito B, Sumi H, Ishikawa T, Ikeda Y.

Chem Pharm Bull (Tokyo). 2015;63(11):858-65. doi: 10.1248/cpb.c15-00262.

11.

Instability in theophylline and carbamazepine hydrate tablets: cocrystal formation due to release of lattice water.

Arora KK, Thakral S, Suryanarayanan R.

Pharm Res. 2013 Jul;30(7):1779-89. doi: 10.1007/s11095-013-1022-7. Epub 2013 Apr 9.

PMID:
23568521
12.

Dissolution kinetics for coprecipitates of diflunisal with PVP K30.

Rodríguez-Espinosa C, Martínez-Ohárriz MC, Martín C, Goñi MM, Vélaz I, Sánchez M.

Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):109-12.

PMID:
9725466
13.

Evaluation of hydrate formation of a pharmaceutical solid by using diffuse reflectance infrared Fourier-transform spectroscopy.

Kojima T, Yamauchi Y, Onoue S, Tsuda Y.

J Pharm Biomed Anal. 2008 Mar 13;46(4):788-91. doi: 10.1016/j.jpba.2007.11.031. Epub 2007 Nov 26.

PMID:
18191525
14.

Determination of the interaction enthalpy between microemulsion droplets by isothermal titration microcalorimetry.

Zheng P, Ma Y, Peng X, Yin T, An X, Shen W.

Langmuir. 2011 Oct 18;27(20):12280-3. doi: 10.1021/la2026686. Epub 2011 Sep 16.

PMID:
21913718
15.

Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.

Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG, Woo JS, Yong CS, Choi HG.

Int J Pharm. 2010 Aug 16;395(1-2):161-6. doi: 10.1016/j.ijpharm.2010.05.023. Epub 2010 May 24.

PMID:
20580799
17.

In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.

Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.

Eur J Pharm Biopharm. 2008 Sep;70(1):302-12. doi: 10.1016/j.ejpb.2008.04.019. Epub 2008 Apr 29.

PMID:
18579353
18.

Solid-state fluorescence studies of some polymorphs of diflunisal*.

Brittain HG, Elder BJ, Isbester PK, Salerno AH.

Pharm Res. 2005 Jun;22(6):999-1006. Epub 2005 Jun 8.

PMID:
15948044
19.

Characterization and stability study of a water-in-oil microemulsion incorporating quercetin.

Vicentini FT, Vaz MM, Fonseca YM, Bentley MV, Fonseca MJ.

Drug Dev Ind Pharm. 2011 Jan;37(1):47-55. doi: 10.3109/03639045.2010.491078. Epub 2010 Jun 15.

PMID:
20550424
20.

Polymorphism and pseudopolymorphism of acyclovir.

Sohn YT, Kim SH.

Arch Pharm Res. 2008 Feb;31(2):231-4.

PMID:
18365695

Supplemental Content

Support Center